NCT05292690

Brief Summary

Preliminary evaluation of an obstacle alerting system to enhance the user's independent mobility by improving their confidence to drive and their safety in driving a powered wheelchair.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 29, 2021

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 2, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 23, 2022

Completed
Last Updated

August 1, 2022

Status Verified

July 1, 2022

Enrollment Period

3 days

First QC Date

February 2, 2022

Last Update Submit

July 28, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Pre-trial Participant Evaluation of the possible Value of an Obstacle Alerting System

    The participant had been given an information sheet describing the Obstacle Alerting System. The participants were given the pre-trial questionnaire to obtain their opinion of the value of the Obstacle Alerting System. In a face to face interview the participants were asked to score each question. 0=don't know, 1=not at all, to 5=very helpful. Participants were also asked to discuss the reasons for their choices. Questions included. Value of warning of obstacles in the vicinity of the powered chair. Use of visual, auditory and haptic feedback in a range of environments e.g. small room, lifts, corridor, doorways, crowded spaces. The value of a reversing camera. Perceived benefit for Powered Chair Users.

    immediately before the intervention/procedure

  • Post-trial Participant Evaluation of the possible Value of the Obstacle Alerting System

    Post-trial questionnaire based on pre-trial questionnaire. Participants reassessed the Obstacle Alerting System \[OAS\] in the light of experience. In a face to face interview the participants were asked to score each question. 0=don't know, 1=not at all, to 5=very helpful. Participants were also asked to discuss the reasons for their choices. Asked when they found the OAS helpful and when unhelpful. Assessment of the feedback options and when they were and were not helpful. How could the OAS be improved to make it more user friendly and environment specific. Perceived benefit for Powered Chair Users.

    immediately after the intervention/procedure

  • Joystick range of movement patterns with and without the Obstacle alerting System Active

    Range of movement scatter plots/ heat maps

    immediately after the intervention/procedure

  • Smoothness of joystick movement with and without the Obstacle alerting System Active

    Smoothness of movement e.g. Normalised Jerk Score. A lower score indicates smoother and more controlled movements. Typical values for this trial are in the range of 3000-5000. A lower score is an indication of the participant learning to drive and becoming more familiar with the course. A lower score may occur with the Obstacle Alerting system active - if it helps. A higher score if it distracts. At present this is a novel measure of these factors

    immediately after the intervention/procedure

  • Joystick path length with and without the Obstacle alerting System Active

    Joystick path length - distance the participant moves the joystick to drive the course. Calculated from the joystick displacement X and Y coordinates. For a set course it would be expected that the path length will decrease as the participant learns to drive and familiarises with the course. Fatigue not having an impact. A lower score may occur with the Obstacle Alerting system active - if it helps. A higher score if it distracts. At present this is a novel measure of these factors

    immediately after the intervention/procedure

  • Time to complete the course with and without the Obstacle alerting System Active

    Manually timed. Start when participant enters the course, stop when exiting the course

    immediately after the intervention/procedure

Interventions

Evaluation of an Obstacle Alerting System

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult non-powered wheelchair users

You may qualify if:

  • Adults who are not wheelchair users.
  • Willing and able to provide a valid consent.
  • Able to participate in interviews aided or unaided using preferred method of communication.
  • Willing to drive a powered chair.

You may not qualify if:

  • \. Lacks capacity to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

East Kent Hospitals NHS Foundation Trust

Canterbury, Kent, CT1 3NG, United Kingdom

Location

MeSH Terms

Conditions

Multiple SclerosisStrokeCystic FibrosisAmyotrophic Lateral SclerosisCraniocerebral TraumaGuillain-Barre Syndrome

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular DiseasesPancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, DiseasesSpinal Cord DiseasesMotor Neuron DiseaseNeurodegenerative DiseasesTDP-43 ProteinopathiesNeuromuscular DiseasesProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic DiseasesTrauma, Nervous SystemWounds and InjuriesPolyradiculoneuropathyPolyneuropathiesPeripheral Nervous System DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Mohamed Sakel, MD

    East Kent Hospitals University Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2022

First Posted

March 23, 2022

Study Start

March 29, 2021

Primary Completion

April 1, 2021

Study Completion

August 31, 2021

Last Updated

August 1, 2022

Record last verified: 2022-07

Locations